Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer

Clinical trial NCT05709574 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05709574
Sponsor: University of Arizona
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2023-04-20
Primary completion: 2026-06-03
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.